/ARBS.MI
ARBS.MI Stock - Arterra Bioscience
Healthcare|BiotechnologyMIL
$3.08+2.67%
+$0.08 (+2.67%) • Dec 22
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.79
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.88
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.39
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ARBS.MI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.05 – $3.11
TARGET (TP)$3.54
STOP LOSS$2.83
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.81
52W High$3.58
52W Low$1.89
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.17M | $3.34M | $3.59M | $4.74M | $2.82M |
| Gross Profit | $3.65M | $1.85M | $492,763 | $673,139 | $30,828 |
| Gross Margin | 87.5% | 55.5% | 13.7% | 14.2% | 1.1% |
| Operating Income | $1.47M | $-356,488 | $365,020 | $1.92M | $-149,950 |
| Net Income | $1.34M | $1.08M | $1.41M | $1.11M | $1.11M |
| Net Margin | 32.0% | 32.3% | 39.4% | 23.4% | 39.3% |
| EPS | $0.20 | $0.16 | $0.21 | $0.17 | $0.17 |
Company Overview
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ARBS.MIBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.12
Q4 2024
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q1 23
No data
Q2 23
No data
Q2 24
No data
Q2 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 8, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.12 | — | — |
Q2 2024 | Jun 29, 2024 | — | $0.08 | — | — |
Q2 2024 | Apr 30, 2024 | — | $0.12 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.04 | — | — |
Q1 2023 | Mar 30, 2023 | — | $0.11 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.10 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.11 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.06 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.12 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.05 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.03 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.13 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.11 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.05 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.06 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ARBS.MI
What is ARBS.MI's current stock price?
Arterra Bioscience (ARBS.MI) is currently trading at $3.08 per share. The stock has moved +2.67% today.
What is the analyst price target for ARBS.MI?
No analyst price targets are currently available for this stock.
What sector is Arterra Bioscience in?
Arterra Bioscience operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the MIL exchange.
What is ARBS.MI's market cap?
Arterra Bioscience has a market capitalization of $0.02 billion, making it a small-cap company.
Does ARBS.MI pay dividends?
No, Arterra Bioscience does not currently pay a dividend to shareholders.